View Older Stories View More Recent Stories

Feb 21, 2025 11:31AM Eli Lilly & Co. (LLY) call put ratio 3.9 calls to 1 put as share price up 2.2%
Feb 20, 2025 05:30AM Eli Lilly & Co. (LLY) call put ratio 1.8 calls to 1 put amid price movement
Feb 19, 2025 04:19PM Eli Lilly & Co. (LLY) Files Mixed Shelf
Feb 10, 2025 05:37PM Eli Lilly announces $6.5 billion six-part note offering
Feb 7, 2025 06:45AM Eli Lilly & Co. (LLY) reports most patients on Omvoh for Crohn's disease achieved sustained clinical remission and endoscopic response at two years
Feb 6, 2025 06:47AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 2c; offers outlook
Feb 6, 2025 05:59AM Bernstein on Eli Lilly (LLY) Following NOVO Read-Across: 'Good News for LLY'
Feb 6, 2025 05:49AM Eli Lilly & Co. (LLY) call put ratio 1.6 calls to 1 put into quarter results
Feb 6, 2025 02:00AM Eli Lilly Q4 earnings preview: Here’s what to expect
Feb 5, 2025 01:35PM Erste Group Upgrades Eli Lilly (LLY) to Buy
Feb 5, 2025 01:20PM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)
Feb 5, 2025 10:37AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put into quarter results
Feb 5, 2025 05:16AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results
Feb 3, 2025 08:50AM Eli Lilly (LLY) PT Raised to $1,038 at Truist on 'Updated FY2024 and Announced FY2025 Guidance'
Jan 30, 2025 01:12PM Eli Lilly & Co. (LLY), Novo (NVO) see mid-day upside
Jan 28, 2025 02:55PM Tectonic shares tumble after rival drug trial termination
Jan 28, 2025 02:50PM Leerink Comments on Tectonic Therapeutics Inc. (TECX) Post Eli Lilly (LLY) Terminating volenrelaxin CKD
Jan 27, 2025 06:37AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY): 'Novo Punches Back, but LLY Still a Step Ahead'
Jan 24, 2025 12:14PM BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)
Jan 23, 2025 10:00PM Eli Lilly & Co. (LLY) Morgan Stanley sees three potential scenarios in the compounders vs. FDA over Tirzepatide
Jan 23, 2025 05:53AM BofA Adjusts US 1 List
Jan 23, 2025 05:18AM Eli Lilly & Co. (LLY) call put ratio 2.1 calls to 1 put
Jan 21, 2025 04:51AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 17, 2025 09:44AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 17, 2025 07:11AM Eli Lilly (LLY) PT Lowered to $973 at Guggenheim
Jan 15, 2025 04:07PM Eli Lilly & Co. (LLY) Announces FDA Approval of Omvoh for Crohn's disease
Jan 15, 2025 10:24AM Bernstein SocGen Group Reiterates Outperform Rating on Eli Lilly (LLY) Despite 'Disappointing' GLP-1 Miss
Jan 15, 2025 05:24AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 15, 2025 04:59AM Wells Fargo Reiterates Overweight Rating on Eli Lilly (LLY)
Jan 15, 2025 04:58AM BofA Securities on Eli Lilly (LLY): 'a particularly good buying opportunity'
Jan 15, 2025 04:54AM Citi Reiterates Buy Rating on Eli Lilly (LLY)
Jan 15, 2025 04:51AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put as share price pulls back
Jan 14, 2025 09:01AM Lilly (LLY) provides update on 2024 revenue guidance, announces 2025 revenue guidance
Jan 13, 2025 01:20PM Eli Lilly & Co. (LLY) Asks Biden Administration to Pause Drug-price Negotiation - Bloomberg
Jan 13, 2025 11:14AM Bernstein Weighs in on US Biopharma Sector in 2025; Highlights LLY as Top-pick
Jan 13, 2025 09:01AM Lilly (LLY) to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program
Jan 10, 2025 01:34PM Eli Lilly (LLY) in advanced talks to buy US cancer biotech for up to $2.5bn - FT
Jan 8, 2025 03:32PM Medicare can now cover Eli Lilly’s (LLY) Zepbound for sleep apnea, CMS says - CNBC
Jan 8, 2025 10:14AM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY); ' Near-term, It's All About GLP-1/Obesity'
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Dec 23, 2024 01:39PM Eli Lilly & Co. (LLY) commends ITC ruling cracking down on the unlawful importation and sale of knock-off tirzepatide products that put Americans at risk
Dec 23, 2024 09:58AM Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
Dec 23, 2024 05:30AM KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results
Dec 20, 2024 10:59AM Eli Lilly & Co. (LLY) call put ratio 1.8 calls to 1 put after Novo Nordisk (NVO) released Cagrisema data
Dec 20, 2024 08:43AM Citi Reiterates Buy Rating on Eli Lilly (LLY)
Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations
Dec 20, 2024 06:23AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY); 'Lilly's Tirzepatide is Officially "No Longer in Shortage"'
Dec 20, 2024 05:39AM Eli Lilly & Co. (LLY) option IV bid into end of year
Dec 19, 2024 09:13AM Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended
Dec 17, 2024 08:01PM Eli Lilly & Co. (LLY) Kisunla Approved in China for Treatment of Early Symptomatic Alzheimer's Disease
View More Recent Stories View Older Stories